The contributors offer a detailed overview of the emerging field of cancer biomarkers--and illustrate the need for improved and more extensive design and clinical trials. Topics include: improving research on biomarkers for early detection and screening of cancers, urine biomarkers for prostate cancer detection, cellular senescence and cancer development, micro RNAs, and mechanistic aspects of oxidative stress involvement in human environmental and occupational carcinogenesis. The intended audience is upper level students, doctors, researchers, biologists, and others in fields related to cancer diagnosis. Editor is Georgakilas (biology, East Carolina U.). Annotation ©2013 Book News, Inc., Portland, OR (booknews.com)
This unique synthesis of chapters from top experts in their fields, targets the very important and upcoming area of cancer biomarkers and the need for better and more rigorous design and clinical trial. The book covers several aspects of cancer molecular markers from innovation, screening, controversies and future directions. The primary target audience for the book includes PhD and MD students, researchers, biologists, medical doctors and professionals who are interested in mechanistic studies on cancer diagnosis and translational benefits from personalized cancer treatment using the new era of biomarkers.
